(Q43199179)

15 November 2017

title

Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm (English)

1 reference

15 November 2017

4

1 reference

15 November 2017

Severine Farley

1

1 reference

15 November 2017

Kalliopi Apazoglou

series ordinal

2

1 reference

15 November 2017

Jeffrey M Witkin

series ordinal

3

1 reference

15 November 2017

Eleni T Tzavara

series ordinal

5

1 reference

15 November 2017

publication date

11 January 2010

1 reference

The International Journal of Neuropsychopharmacology

15 November 2017

published in

1 reference

15 November 2017

volume

13

1 reference

15 November 2017

issue

9

1 reference

15 November 2017

page(s)

1207-1218

1 reference

Selective cortical VGLUT1 increase as a marker for antidepressant activity

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

AMPA receptors in the therapeutic management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Intra- and interstrain differences in models of "behavioral despair".

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

A role for AMPA receptors in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Enhancement of antidepressant potency by a potentiator of AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Food-induced behavioral sensitization, its cross-sensitization to cocaine and morphine, pharmacological blockade, and effect on food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Chronic valproate normalizes behavior in mice overexpressing calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709991076

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1461145709991076

1 reference

15 November 2017

1 reference